Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price shot up 21.2% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. 292,294 shares were traded during trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The business has a 50-day moving average price of C$0.10 and a two-hundred day moving average price of C$0.07. The firm has a market capitalization of C$27.89 million, a price-to-earnings ratio of -20.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Profit From Growth Investing
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- CD Calculator: Certificate of Deposit Calculator
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
